AIDS

1. SALTO JN, Volkow P, Herrera-Goepfert R, Lopez-Garcia AI, et al
   Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS.
   AIDS. 2024;38:933-934.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

2. CHANDASANA H, Singh R, Adkison K, Ait-Khaled M, et al
   Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.
   Antimicrob Agents Chemother. 2024 Apr 8:e0150423. doi: 10.1128/aac.01504.
   

   >> Share

   
   

   
   Clin Infect Dis

3. WOHL DA, Koethe JR, Sax PE, McComsey GA, et al
   Antiretrovirals and Weight Change: Weighing the Evidence.
   Clin Infect Dis. 2024 Apr 12:ciae191. doi: 10.1093.
   

   >> Share

   
   
4. HILL A
   Which form of tenofovir should be used worldwide: TDF or TAF?
   Clin Infect Dis. 2024 Apr 12:ciae190. doi: 10.1093.
   

   >> Share

   
   
5. DAMAS J, Munting A, Fellay J, Haerry D, et al
   Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
   Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

6. TURK T, Labarile M, Braun DL, Rauch A, et al
   CHARACTERIZATION AND DETERMINANTS OF LONG-TERM IMMUNE RECOVERY UNDER SUPPRESSIVE ANTIRETROVIRAL THERAPY.
   J Acquir Immune Defic Syndr. 2024 Jan 24. doi: 10.1097/QAI.0000000000003388.
   

   >> Share

   
   

   
   N Engl J Med

7. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
   Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
   N Engl J Med. 2024;390:1186-1195.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share